HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$4.50
Day range
$4.43 - $4.66
Year range
$3.25 - $10.45
Market cap
385.12M USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.05M | -10.36% |
Net income | -10.55M | 19.54% |
Net profit margin | — | — |
Earnings per share | -0.13 | 23.53% |
EBITDA | — | — |
Effective tax rate | -1.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 139.39M | -9.18% |
Total assets | 144.52M | -9.22% |
Total liabilities | 9.56M | -31.83% |
Total equity | 134.96M | — |
Shares outstanding | 84.64M | — |
Price to book | 2.80 | — |
Return on assets | -20.59% | — |
Return on capital | -22.27% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.55M | 19.54% |
Cash from operations | -11.66M | -37.31% |
Cash from investing | — | — |
Cash from financing | 7.28M | -60.31% |
Net change in cash | -4.38M | -144.48% |
Free cash flow | -8.64M | -86.76% |
About
Founded
2004
Headquarters
Website
Employees
40